DE69825128D1 - Verwendung von azithromycin zur topischen behandlung von augeninfektionen - Google Patents

Verwendung von azithromycin zur topischen behandlung von augeninfektionen

Info

Publication number
DE69825128D1
DE69825128D1 DE69825128T DE69825128T DE69825128D1 DE 69825128 D1 DE69825128 D1 DE 69825128D1 DE 69825128 T DE69825128 T DE 69825128T DE 69825128 T DE69825128 T DE 69825128T DE 69825128 D1 DE69825128 D1 DE 69825128D1
Authority
DE
Germany
Prior art keywords
azithromycin
topical treatment
eye infection
treatment
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69825128T
Other languages
English (en)
Other versions
DE69825128T2 (de
DE69825128T3 (de
Inventor
Imran Ahmed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69825128(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE69825128D1 publication Critical patent/DE69825128D1/de
Publication of DE69825128T2 publication Critical patent/DE69825128T2/de
Publication of DE69825128T3 publication Critical patent/DE69825128T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DE69825128T 1997-12-02 1998-11-12 Verwendung von azithromycin zur topischen behandlung von augeninfektionen Expired - Lifetime DE69825128T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6725097P 1997-12-02 1997-12-02
US67250P 1997-12-02

Publications (3)

Publication Number Publication Date
DE69825128D1 true DE69825128D1 (de) 2004-08-26
DE69825128T2 DE69825128T2 (de) 2005-07-28
DE69825128T3 DE69825128T3 (de) 2010-05-06

Family

ID=22074743

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825128T Expired - Lifetime DE69825128T3 (de) 1997-12-02 1998-11-12 Verwendung von azithromycin zur topischen behandlung von augeninfektionen

Country Status (11)

Country Link
EP (1) EP0925789B2 (de)
JP (1) JPH11240838A (de)
AT (1) ATE271390T1 (de)
BR (1) BR9805318A (de)
CA (1) CA2254682C (de)
CY (1) CY1105482T1 (de)
DE (1) DE69825128T3 (de)
DK (1) DK0925789T4 (de)
ES (1) ES2221127T5 (de)
MX (1) MX232591B (de)
PT (1) PT925789E (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
DE10006560A1 (de) 2000-02-15 2001-08-23 Disetronic Licensing Ag Zweikomponentiger Kolbenstopfen
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
EP1563850A3 (de) * 2000-02-23 2008-02-20 Pfizer Products Inc. Verfahren zur Erhöhung der Bioverfügbarkeit und dem Eindringen in Gefässe von Azithromycin
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
EP1671979B1 (de) 2001-05-22 2008-08-13 Pfizer Products Inc. Neue Kristallforme von Azithromycin
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
EP1691786A1 (de) 2003-12-04 2006-08-23 Pfizer Products Inc. Multiteilchenförmige zusammensetzungen mit verbesserter stabilität
BRPI0417360A (pt) 2003-12-04 2007-03-13 Pfizer Prod Inc método para a preparação de multiparticulados farmacêuticos
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
KR101130252B1 (ko) 2004-07-02 2012-03-26 와카모토 세이야꾸 가부시끼가이샤 아지스로마이신 함유 수성 의약 조성물 및 그 조제 방법
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
JPWO2007074904A1 (ja) * 2005-12-28 2009-06-04 わかもと製薬株式会社 水性医薬組成物
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
WO1995009601A1 (en) * 1993-10-01 1995-04-13 The Procter & Gamble Company Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5610198A (en) † 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
AU4399396A (en) * 1994-12-19 1996-07-10 Russinsky Limited Compounds
US5872104A (en) * 1994-12-27 1999-02-16 Oridigm Corporation Combinations and methods for reducing antimicrobial resistance
ATE287673T1 (de) † 1995-06-07 2005-02-15 Southern Biosystems Inc Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität

Also Published As

Publication number Publication date
EP0925789B1 (de) 2004-07-21
DE69825128T2 (de) 2005-07-28
ES2221127T3 (es) 2004-12-16
BR9805318A (pt) 2000-04-11
CA2254682A1 (en) 1999-06-02
ATE271390T1 (de) 2004-08-15
DK0925789T4 (da) 2009-07-13
JPH11240838A (ja) 1999-09-07
MX232591B (es) 2005-12-02
CY1105482T1 (el) 2010-04-28
ES2221127T5 (es) 2009-11-10
DK0925789T3 (da) 2004-10-25
EP0925789A1 (de) 1999-06-30
EP0925789B2 (de) 2009-06-17
PT925789E (pt) 2004-10-29
DE69825128T3 (de) 2010-05-06
CA2254682C (en) 2003-07-08

Similar Documents

Publication Publication Date Title
DE69825128D1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
DE69903543T2 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE69907664D1 (de) Verfahren zur Herstellung von wässrigen Formulierungen für ophthalmische Verwendung
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DE69521620T2 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
PT842934E (pt) Agonistas de 5-ht1f
DE60101265D1 (de) Behandlung von augenschmerzen
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE69106586D1 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
DE69907418T2 (de) Verwendung von makroliden zur behandlung von glaukom
ES2191075T3 (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv.
FI935777A (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69617005D1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
DE69307674T2 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
ID25478A (id) Agonis 5-ht1f
DE69810724T2 (de) Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC)
ATE241640T1 (de) Fusidinsäure-derivate
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, 80539